The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2-Reference-Cited by-同舟云学术

The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C₁₉H₁₇BrN₂O₂S₂

Published:2024-02-28 Issue:3 Volume:239 Page:379-380
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Ni Lei-Qiang¹,Guo Xiao-Meng¹,Wang Ze-Lin¹,Sun Juan¹^ORCID

Affiliation:

1. School of Biological and Chemical Engineering , Zhejiang University of Science and Technology , Hangzhou , Liuhe Road 318# , China

Abstract

Abstract C19H17BrN2O2S2, triclinic, P 1 ‾

$P\overline{1}$

(no. 2), a = 7.8069(5) Å, b = 8.0787(5) Å, c = 15.7738(9) Å, α = 97.540(2)°, β = 90.179(2)°, γ = 104.507(2)°, V = 954.13(10) Å3, Z = 2, R gt(F) = 0.0423, wR ref(F 2) = 0.1134, T = 296.15 K.

Funder

National Undergraduate Training Programs for Innovation and Entrepreneurship

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2024-0009/pdf

Reference6 articles.

1. Bruker. Apex3 v. 2016.9-0 and Saint v. 8.37A; Bruker Axs Inc.: Madison, Wisconsin, USA, 2016.

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. Olex2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

3. Sheldrick, G. M. Shelxtl – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8.

4. Sheldrick, G. M. Crystal structure refinement with Shelxl. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.

5. Cheng, K., Xue, J. Y., Zhu, H. L. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors. Bioorg. Med. Chem. Lett. 2013, 23, 4235–4238; https://doi.org/10.1016/j.bmcl.2013.05.006.